Medical Devices: Page 4


  • A person points to a large screen showing vital signs.
    Image attribution tooltip
    Permission granted by Will Kirk / Johns Hopkins University
    Image attribution tooltip

    Bayesian Health gets FDA nod for AI sepsis detection tool

    Created by Johns Hopkins University researchers, the early warning system for sepsis aims to help physicians detect the serious condition earlier.

    By May 12, 2026
  • The Stryker logo is displayed on an office building with hills in the background.
    Image attribution tooltip
    JHVEPhoto via Getty Images
    Image attribution tooltip

    Stryker values Amplitude Vascular purchase at up to $835M

    The deal for Amplitude’s intravascular lithotripsy platform, which closed last week, includes $435 million upfront and up to $400 million in milestone payments.

    By May 12, 2026
  • Intuitive Surgical's da Vinci 5 robotic system. Explore the Trendline
    Image attribution tooltip
    Courtesy of Intuitive Surgical
    Image attribution tooltip
    Trendline

    Robotic surgery's innovation boom

    Surgical robotics is one of the most exciting spaces in the medical device industry, with companies developing new systems and battling for market share.

    By MedTech Dive staff
  • Histosonics' Edison histotripsy system is pictured in an operating room.
    Image attribution tooltip
    Permission granted by Histosonics
    Image attribution tooltip

    HistoSonics seeks FDA de novo authorization in kidney cancer

    Investors including Bezos Expeditions and Thiel Bio supported HistoSonics’ expansion plans last year by participating in a $250 million financing round.

    By May 12, 2026
  • The Medtronic logo is displayed on an office building.
    Image attribution tooltip
    Retrieved from Medtronic on May 11, 2026
    Image attribution tooltip

    Medtronic to close California site amid restructuring

    The decision to wind down the operation in Santa Rosa in about two years comes as the medtech giant combines several businesses within its cardiovascular portfolio.

    By May 11, 2026
  • A group of people stands in Times Square in front of a large ad thaqt says "Welcome to NASDAQ Mobia Medical."
    Image attribution tooltip
    Permission granted by Mobia Medical
    Image attribution tooltip

    Mobia Medical CEO eyes large market for stroke rehab

    With a recent initial public offering, CEO Richard Foust hopes to make the company’s vagus nerve stimulation treatment the standard of care for stroke.

    By May 11, 2026
  • Becton Dickinson logo
    Image attribution tooltip
    Permission granted by Becton Dickinson
    Image attribution tooltip

    BD appoints Vitor Roque as permanent CFO

    The company made Roque’s appointment permanent after considering external candidates for the role.

    By May 11, 2026
  • A person walks in a forest with a square device taped to their thigh.
    Image attribution tooltip
    Courtesy of Tandem Diabetes Care
    Image attribution tooltip

    Tandem to file tubeless insulin pump with FDA this quarter

    The new version of Tandem’s Mobi pump would be the diabetes technology company’s first tubeless device.

    By May 8, 2026
  • A picture of a large building with the name "Stryker" across it and a pond with a swan in the foreground.
    Image attribution tooltip
    Retrieved from Stryker Corporation on January 06, 2025
    Image attribution tooltip

    Stryker closes Amplitude Vascular acquisition

    With an intravascular lithotripsy platform, Stryker will enter a booming market that has attracted investment from Johnson & Johnson, Boston Scientific and Abbott.

    By May 8, 2026
  • A modern office building at the Roche Diagnostics campus features a sleek glass façade with the Roche logo displayed near the entrance, and the structure is surrounded by landscaped greenery.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Roche to acquire digital pathology firm PathAI for up to $1.05B

    Roche plans to offer PathAI’s tools as part of an effort to improve cancer diagnosis and tailored treatment.

    By May 7, 2026
  • An image of a GI robot.
    Image attribution tooltip
    Permission granted by Neptune Medical
    Image attribution tooltip

    Neptune Medical’s GI robot succeeds in colonoscopy study

    The first-in-human study showed no adverse events and a 100% rate of cecal intubation, where the endoscope is guided to the beginning of the large intestine.

    By May 6, 2026
  • A person sits in front of a plate of food, holding a smartphone. They're wearing a patch on their left arm.
    Image attribution tooltip
    Courtesy of Insulet Corp.
    Image attribution tooltip

    Insulet raises revenue expectations for 2026

    CEO Ashley McEvoy also shared an update on the company’s recent recall of insulin patch pumps.

    By May 6, 2026
  • A wall bearing the Johnson & Johnson logo is seen outside of an office building.
    Image attribution tooltip
    Courtesy of Johnson & Johnson
    Image attribution tooltip

    J&J’s Ottava robot meets goals in gastric bypass study

    The findings for patients 30 days after surgery were included in a package of data supporting J&J’s submission to the FDA for de novo authorization.

    By May 6, 2026
  • A headshort of Stuart Essig CEO Integra
    Image attribution tooltip
    Courtesy of Integra LifeSciences
    Image attribution tooltip

    Integra reappoints Stuart Essig as CEO

    Essig filled the vacancy created when Mojdeh Poul and the Integra board mutually decided to end her time as CEO after less than 18 months.

    By May 6, 2026
  • Engraving on a wall reads "wall street."
    Image attribution tooltip
    Spencer Platt via Getty Images
    Image attribution tooltip

    Mobia Medical plans IPO

    The neurostimulation device company intends to offer 10 million shares for between $14 and $16 each.

    By May 5, 2026
  • A headshot of incoming Edwards Lifesciences CFO Theodora “Doretta” Mistras.
    Image attribution tooltip
    Retrieved from Viatris on May 05, 2026
    Image attribution tooltip

    Edwards names Theodora Mistras as CFO

    Mistras, who joins the heart valve company after two years as CFO at pharmaceutical firm Viatris, also brings investment banking experience.

    By May 5, 2026
  • An illustration of two EndoRobotics articulated grippers.
    Image attribution tooltip
    Permission granted by EndoRobotics
    Image attribution tooltip

    Olympus, EndoRobotics forge distribution pact

    The deal to distribute EndoRobotics’ endoscopic robotic devices for gastroenterology follows Olympus’ agreement to co-launch Swan EndoSurgical, a startup developing a robotic GI platform.

    By May 4, 2026
  • A person runs in a soccer field wearing two white devices taped to their upper arms.
    Image attribution tooltip
    Courtesy of Insulet
    Image attribution tooltip

    Insulet starts study of closed loop insulin delivery system

    Indicated for people with Type 2 diabetes, the system would be Insulet’s first fully automated device for insulin delivery.

    By May 4, 2026
  • Professional photo of Joe Almeida
    Image attribution tooltip
    Permission granted by Baxter
    Image attribution tooltip

    Top medtech executive moves in 2026

    Integra LifeSciences has reappointed Stuart Essig as CEO, and Edwards Lifesciences and BD named new CFOs. Read MedTech Dive’s roundup for all the details.

    By MedTech Dive Staff • Updated May 20, 2026
  • Modern glass and metal office building with a reflective blue-tinted facade, set against a clear blue sky. In the foreground, a large black and white sign reads “Abbott” with the company’s stylized logo and the number “645.” The area has neatly cut grass and a few small trees.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Abbott gets FDA nod, CE mark for AI-enabled imaging device

    The device joins a portfolio of vascular technologies that generated 9.5% sales growth on a comparable basis in the first quarter.

    By May 4, 2026
  • A headshot of new Teleflex CEO Jason Weidman.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Teleflex hires Jason Weidman as CEO

    After two decades at Medtronic, Weidman will join Teleflex as the medtech company reshapes its portfolio.

    By April 30, 2026
  • Two black, rounded devices next to each other give the same reading of 102 mg/dL.
    Image attribution tooltip
    Courtesy of Trividia Health
    Image attribution tooltip

    FDA advises users of Trividia glucometer to switch to alternatives

    The potential for error code confusion to cause delayed or improper treatment led the FDA to recommend users transition to other blood glucose meters.

    By April 30, 2026
  • A closeup of the porcine heart valve against a white background.
    Image attribution tooltip
    Permission granted by Medtronic
    Image attribution tooltip

    Medtronic wins FDA approval for updated mitral replacement valve

    Surgeons have performed initial implants of the Mosaic Neo valve at centers across the U.S., as well as the first robotic implantation.

    By April 29, 2026
  • Two clinicians operate Distalmotion's Dexter robotic system in an operating room.
    Image attribution tooltip
    Permission granted by Distalmotion
    Image attribution tooltip
    Profile

    Surgeries are moving to ASCs. Distalmotion wants its robot to drive the shift.

    CEO Greg Roche says ambulatory surgery centers have largely lacked access to robots for performing soft tissue procedures, until now.

    By April 29, 2026
  • Medtronic's Stealth AXiS system.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic secures CE mark for Stealth AXiS surgical system

    Receiving the clearance positions Medtronic to launch a product that combines surgical planning, navigation and robotics in Europe.

    By April 29, 2026
  • A picture of a blue pulsed field ablation catheter against a gray background.
    Image attribution tooltip
    Courtesy of Johnson & Johnson MedTech
    Image attribution tooltip

    J&J starts head-to-head PFA trial against Boston Scientific device

    The study will compare outcomes on J&J’s Varipulse Pro platform and Boston Scientific’s rival Farapulse PFA system.

    By April 28, 2026